Skip to main content

National Institutes of Health

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Active

Decision brief

Who can apply
Higher EducationGovernmentSmall BusinessNonprofitsOtherNonprofits (preferred)
Award amount
Up to $1.5M
Deadline
Mar 5, 2027
Geography
National
Application notesMedium effort
  • Federal application

Next step

Apply at Grants.gov

Apply Now

Focus areas

About this grant

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Additional details

CFDA / ALN Number
93.279
Program Title
Drug Abuse and Addiction Research Programs
Funding Instrument
Grant
Source
Grants.gov · View original listing

Similar grants